Science Explorer Interactive view Map
Company · New York · United States

Intercept Pharmaceuticals (United States)

interceptpharma.comROR OpenAlex
Research works
79
▼ 21% vs 2013–17
Citations
4.7k
59.7 per fractional work
Top-10% rate
29.3%
record average 16.5%
Open access
47%
world 28%

Not ranked overall: Intercept Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.43× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.71× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 1.55× its world share, 0 worksImmunology and Micro…Computer Science: 0.26× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.86× its world share, 0 worksEarth and Planetary …Engineering: 0.18× its world share, 0 worksEngineeringDentistry: 2.09× its world share, 0 worksDentistryHealth Professions: 0.10× its world share, 0 worksHealth ProfessionsMedicine: 3.88× its world share, 12 worksMedicineArts and Humanities: 0.70× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.68× its world share, 0 worksBusiness, Management…Decision Sciences: 0.19× its world share, 0 worksDecision SciencesSocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.

Who are the top researchers at Intercept Pharmaceuticals (United States)?

Ranked on the composite score, Leigh MacConell lead among researchers whose main affiliation is Intercept Pharmaceuticals (United States).

  1. 1 Leigh MacConell United States · #1,064,678 worldwide 24 citations · 23 works
All ranked researchers at Intercept Pharmaceuticals (United States)

Which keywords describe research at Intercept Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Liver Transplantation, Nuclear Receptors, Metabolic Regulation, Diagnosis, Metabolic Syndrome, Pathogenesis, Epidemiology and Management.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology13▲ 3.9×27 topics
  2. Liver Transplantation12▲ 95×4 topics
  3. Nuclear Receptors10▲ 71×5 topics
  4. Diagnosis9▲ 11×7 topics
  5. Metabolic Regulation9▲ 41×4 topics
  6. Metabolic Syndrome9▲ 13×13 topics
  7. Pathogenesis9▲ 20×5 topics
  8. Management9▲ 14×5 topics
  9. ATP-dependent Transporters9▲ 211×1 topic
  10. Multidrug Resistance9▲ 182×1 topic
  11. Insulin Resistance9▲ 23×10 topics
  12. Inflammation8▲ 4.5×32 topics
  13. Immunosuppressive Therapy8▲ 55×3 topics
  14. Autoimmune Hepatitis8▲ 536×1 topic
  15. Primary Biliary Cirrhosis8▲ 536×1 topic
  16. Hepatocellular Carcinoma8▲ 46×3 topics
  17. Hepatic Steatosis7▲ 62×2 topics
  18. NAFLD7▲ 82×1 topic
  19. NASH7▲ 82×1 topic
  20. Oxidative Stress4▲ 2.5×19 topics
  21. Metabolism3▲ 6.6×5 topics
  22. Etiology3▲ 51×2 topics
  23. Alagille Syndrome2▲ 105×1 topic
  24. Biliary Atresia2▲ 105×1 topic
  25. Obesity2▲ 4.2×10 topics
  26. Atherosclerosis2▲ 8.0×6 topics
  27. Cholangiocarcinoma2▲ 32×2 topics
  28. Cholesterol2▲ 13×3 topics
  29. Transcriptional Regulation2▲ 9.6×6 topics
  30. Cholecystitis2▲ 52×1 topic
  31. Diabetes2▲ 4.4×9 topics
  32. ERCP2▲ 52×1 topic
  33. Angiogenesis2▲ 5.3×5 topics
  34. HDL2▲ 81×2 topics
  35. Circadian Rhythms2▲ 24×2 topics
  36. LXR2▲ 95×1 topic
  37. SREBP2▲ 95×1 topic
  38. Liver Disease2▲ 13×3 topics
  39. Macrophages1▲ 11×4 topics
  40. TGF-ß1▲ 9.7×4 topics

Which research topics does Intercept Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Drug Transport and Resistance Mechanisms and Gallbladder and Bile Duct Disorders.

Liver Diseases and Immun…3Liver Diseases and Immunity: 3 fractional worksLiver Disease Diagnosis and Treatment: 2 fractional worksDrug Transport and Resistance Mechanisms: 2 fractional worksGallbladder and Bile Duct Disorders: 1 fractional worksPediatric Hepatobiliary Diseases and Treatments: 1 fractional worksHepatitis B Virus Studies: 0 fractional worksHelicobacter pylori-related gastroenterology studies: 0 fractional worksTransportation Systems and Infrastructure: 0 fractional worksDiverse Research and Applications: 0 fractional worksFood Supply Chain Traceability: 0 fractional works
HepatologyEpidemiologyOncologyPulmonary and Respiratory Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Liver Diseases and Immunity Hepatology 3 works
  2. 2 Liver Disease Diagnosis and Treatment Epidemiology 2 works
  3. 3 Drug Transport and Resistance Mechanisms Oncology 2 works
  4. 4 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 1 works
  5. 5 Pediatric Hepatobiliary Diseases and Treatments Surgery 1 works
  6. 6 Hepatitis B Virus Studies Epidemiology 0 works
  7. 7 Helicobacter pylori-related gastroenterology studies Surgery 0 works
  8. 8 Transportation Systems and Infrastructure Management of Technology and Innovation 0 works
  9. 9 Diverse Research and Applications Information Systems 0 works
  10. 10 Food Supply Chain Traceability Food Science 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.7%not open53.3%

World: 28% of research is openly available.

with international co-authors56.6%domestic only43.4%

World: 19% is written across borders.

How has Intercept Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 21% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New York

All research institutions in New York

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.